# Chemotherapy With or Without Wobe-Mugos E in Treating Patients With Stage II or Stage III Multiple Myeloma

> **NCT00014339** · PHASE3 · UNKNOWN · sponsor: **Medsearch**

## Conditions studied

- Multiple Myeloma and Plasma Cell Neoplasm

## Interventions

- **DRUG:** Wobe-Mugos E
- **DRUG:** melphalan
- **DRUG:** prednisone
- **PROCEDURE:** quality-of-life assessment

## Key facts

- **NCT ID:** NCT00014339
- **Lead sponsor:** Medsearch
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2000-03
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2013-12-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00014339

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00014339, "Chemotherapy With or Without Wobe-Mugos E in Treating Patients With Stage II or Stage III Multiple Myeloma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00014339. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*